|
|
BioPortfolio - donepezil solubility
donepezil solubility - BioPortfolio ... Memantine (Namenda ) A new option FOR alzheimer’s disease ... (Aricept) and memantine (Namenda) target either ...
MEMANTINE
SOLUBILITY IN WATER. soluble. pH. 3.5 - 4.5. VAPOR DENSITY. AUTOIGNITION. NFPA RATINGS ... Memantine is an NMDA(N-methyl-D-aspartate) receptor antagonist used ...
MEMANTINE HYDROCHLORIDE : MP Biomedicals : Buy Online
HydrochloridePurity: >98%An NMDA receptor antagonist and dopamine ... Solubility: Soluble in water (16 mg/ml) References: Merck Index 11th Ed., No. 5709 ...
Erowid Experience Vaults: Memantine - A Few Words of Caution - 32398
An experience with Memantine. 'A Few Words of Caution' by Lazyvegan ... I have determined that memantine is indeed a psychoactive substance. ...
Memantine.Hydrochloride by A.G. Scientific, Biochemical Manufacturer
Memantine.Hydrochloride - may be purchased online from A.G. ... Solubility: Readily Soluble in Water. CAS Number: CAS [19982-08-2] Active Product: Yes ...
DrugBank: Showing Memantine (DB01043)
Predicted Water Solubility. 4.55e-02 mg/mL Calculated using ALOGPS ... Memantine, an amantadine derivative, is an NMDA receptor antagonist used in the ...
Data Sheet
The solubility of memantine hydrochloride in water at room temperature is about ... Memantine is a rapid, strongly voltage-dependent, uncompetitive NMDA ...
Product Information
Memantine hydrochloride. Rammes, G., Rupprecht, R., Ferrari, U., et al. Neurosci. Letters. ... Solubility: Stability (in original shipping container): CAS ...
Adamantane - Wikipedia, the free encyclopedia
Solubility in other solvents. Soluble in hydrocarbons. Structure ... Adamantane derivatives are useful in medicine, e.g. amantadine, memantine and rimantadine. ...
Venlafaxine osmotic device formulation - Patent Application 20070077301
Memantine is used as an anti-Alzheimer's drug or an anti-Parkinson's drug. ... of polymeric materials are known to possess these various solubility properties. ...
|
|
|
|
Memantine solubility |
PHARMACEUTICAL COMPOSITION OF MEMANTINE - Patent Application WO/2008/065339
Present invention provides pharmaceutical composition comprising memantine or a pharmaceutically acceptable salt thereof as well as a method for its production. Also provided are different formulations of the composition their structure and preferred shape.
15. A composition as claimed in claim 14 wherein polymer is selected from the group consisting of cellulose based polymer, polyethyleneglycol, polyvinylalcohol, chitosan, lactic acid, copolymers of lactic and glycolic acid, polymethacrylates, methacrylic acid copolymers, polyethylene glycol, xanthan gum, guar gum, or combination thereof.
38. A process for preparation of the composition claimed in claims 1 to 35 comprising following steps: a. intermixing of memantine or a pharmaceutically acceptable salt thereof with one or more fillers, glidants and lubricants and with one or more lipidic drug release rate controlling substances; b.
|
Rating: 3.5 èç 5 (ãîëîñîâ: 151) |
|
27 january 2008
Âàëåðèé Êîëîáêîâ
|
|
|
|
|
memantine mechanism of action
memantine schizophrenia
memantine clinical trial
of memantine hcl
|
|
|
|
|
|
|
|
|
|
|